M. Migden, “Health-Related Quality of Life (HRQL) in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC) Treated with Cemiplimab: Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial”, J of Skin, vol. 4, no. 6, p. s122, Oct. 2020.